Academic Journal

Myco-assisted zinc oxide nanoparticles by Aspergillus sp. SA18: Chemical profiling, antimicrobial, anticancer, and computational insights into GyrA and GyrB inhibition with ADME physicochemical properties.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Myco-assisted zinc oxide nanoparticles by Aspergillus sp. SA18: Chemical profiling, antimicrobial, anticancer, and computational insights into GyrA and GyrB inhibition with ADME physicochemical properties.
Συγγραφείς: El Hawary S; Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Giza, Egypt., El-Sayyad GS; Biology Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi Arabia. Electronic address: gelsayyd@imamu.edu.sa., El Raey MA; Department of Phytochemistry and Plant Systematics, Pharmaceutical Division, National Research Centre, 33 El Bohouth Street, P.O. Box 12622, Dokki, Cairo, 12622, Egypt., Abdelrahman SESAH; Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Giza, Egypt., Mohsen E; Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Giza, Egypt., Bendif H; Biology Department, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi Arabia., Hamed AA; Microbial Chemistry Department, National Research Centre, 33 El-Buhouth Street, Dokki, Giza, 12622, Egypt., Ghareeb MA; Medicinal Chemistry Department, Theodor Bilharz Research Institute, Kornish El-Nile, Warrak El-Hadar, Imbaba, Giza, 12411, Egypt. Electronic address: m.ghareeb@tbri.gov.eg.
Πηγή: Archives of biochemistry and biophysics [Arch Biochem Biophys] 2026 Nov; Vol. 785, pp. 110952. Date of Electronic Publication: 2026 Aug 01.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: Elsevier Country of Publication: United States NLM ID: 0372430 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0384 (Electronic) Linking ISSN: 00039861 NLM ISO Abbreviation: Arch Biochem Biophys Subsets: MEDLINE
Imprint Name(s): Publication: <2000- > : San Diego, CA : Elsevier
Original Publication: New York, NY : Academic Press
Ιατρικοί όροι (MeSH): Aspergillus*/chemistry , Aspergillus*/metabolism , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/metabolism , Zinc Oxide*/chemistry , Zinc Oxide*/pharmacology , Zinc Oxide*/metabolism , DNA Gyrase*/metabolism , DNA Gyrase*/chemistry , Anti-Infective Agents*/pharmacology , Anti-Infective Agents*/chemistry , Anti-Infective Agents*/metabolism , Metal Nanoparticles*/chemistry, Candida albicans/drug effects ; Pseudomonas aeruginosa/drug effects ; Nanoparticles/chemistry ; Humans ; MCF-7 Cells ; Molecular Docking Simulation ; Hep G2 Cells
Περίληψη: This study aimed to biosynthesize zinc oxide nanoparticles (ZnONPs) using a marine-derived Aspergillus sp. SA18 fungal extract and assess their antimicrobial and anticancer properties. ZnONPs were characterized by UV-Vis. spectroscopy, FTIR, XRD, TEM, SEM, and zeta potential analyses. Characterization approved successful nanoparticle synthesis, with a crystalline structure and an average particle size of 75 nm based on XRD analysis, while TEM and SEM exposed polydisperse spherical particles ranging from 80 to 96 nm. The synthesized ZnONPs showed a zeta potential of -21.03 mV, demonstrating good colloidal stability. Antimicrobial test demonstrated prominent activity, with the fungal extract displaying the highest inhibition zones against Pseudomonas aeruginosa and Candida albicans (16 mm each). Cytotoxicity assessment disclosed strong anticancer activity of the fungal extract against MCF-7 and HepG2 cell lines, with IC50 values of 9.75 ± 0.7 and 22.81 ± 1.7 μM, respectively, while ZnONPs displayed IC50 values of 46.11 ± 2.7 and 74.96 ± 3.8 μM against the same cell lines. Chemical profiling identified 48 metabolites, including flavonoids and phenolic acids, which may contribute to the observed bioactivities. Molecular docking showed strong binding affinities of xanthohumol toward E. coli GyrB (docking score = -8.47 kcal/mol) and herbacetin toward c-Src kinase (docking score = -8.81 kcal/mol), supported by molecular dynamics simulations and favorable ADME properties. These findings prove that Aspergillus sp. SA18-mediated ZnONPs possess auspicious antimicrobial and anticancer potential and highlight this marine fungal isolate as an efficient nanofactory for biomedical applications.
(Copyright © 2026 Elsevier Inc. All rights reserved.)
Competing Interests: Competing interests No conflict of interests.
Contributed Indexing: Keywords: Antimicrobial; Aspergillus sp. SA18; DNA gyrase-ADME-Toxicity prediction; Good health and well-being; ZnONPs
Substance Nomenclature: 0 (Antineoplastic Agents)
SOI2LOH54Z (Zinc Oxide)
EC 5.99.1.3 (DNA Gyrase)
0 (Anti-Infective Agents)
Entry Date(s): Date Created: 20260801 Date Completed: 20260905 Latest Revision: 20260905
Update Code: 20260906
DOI: 10.1016/j.abb.2026.110952
PMID: 42542237
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:1096-0384
DOI:10.1016/j.abb.2026.110952